<DOC>
<DOCNO>
EP-0000645
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
C07D-205/085 C07D-513/00 A61P-31/00 C07D-499/00 C07D-513/04 A61K-31/425 <main>C07D-513/04</main> C07D-205/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
isopenicillins, processes for their preparation, and compositions containing them.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline corporation<sep>
</APPLICANT>
<INVENTOR>
hall ralph floyd<sep>huffman william francis<sep>hall, ralph floyd<sep>huffman, william francis<sep>hall, ralph floydprinceton arms north apt. 227cranbury new jersey 08512us<sep>huffman, william francis40 crest avenuemalvern pennsylvania 19355us<sep>hall, ralph floyd<sep>huffman, william francis<sep>hall, ralph floydprinceton arms north apt. 227cranbury new jersey 08512us<sep>huffman, william francis40 crest avenuemalvern pennsylvania 19355us<sep>
</INVENTOR>
<ABSTRACT>
isopenicillins of the formula    in which   r is acylamino, azido, or amino; and   m is hydrogen, a pharmaceutically acceptable cation, or a  removable carboxylic acid protecting ester, can be prepared  by ring-closing an appropriately 3-substituted-4- halomethyl  β-lactam of the formula    in which   r′ is acylamino or azido;   and when a compound (1) is required, in which r is amino, a  protecting acyl group of an acylamino group r′ is removed.   compound i show antibacterial activity against gram positive  and gram negative organisms.  
</ABSTRACT>
</TEXT>
</DOC>
